We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
-2.57%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$86.2B
AUM Growth
-$3.13B
(-3.5%)
Cap. Flow
+$224M
Cap. Flow
% of AUM
0.26%
Top 10 Holdings %
Top 10 Hldgs %
24.96%
Holding
4,488
New
66
Increased
2,157
Reduced
1,702
Closed
141
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kenvue
KVUE
|
+$72.5M |
| 2 |
iShares Russell 1000 ETF
IWB
|
+$54.4M |
| 3 |
Blackstone
BX
|
+$44M |
| 4 |
Airbnb
ABNB
|
+$37.4M |
| 5 |
Everest Group
EG
|
+$30.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$57.8M |
| 2 |
LSI
Life Storage, Inc.
LSI
|
+$39.6M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$23.8M |
| 4 |
iShares Global Infrastructure ETF
IGF
|
+$19.2M |
| 5 |
PDCE
PDC Energy, Inc.
PDCE
|
+$18.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.73% |
| 2 | Healthcare | 12.76% |
| 3 | Financials | 12.67% |
| 4 | Consumer Discretionary | 11.16% |
| 5 | Industrials | 9.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1951
Procept Biorobotics
PRCT
$1.17B
| $1.62M | ﹤0.01% |
49,515
+1,971
| +4% | +$67.2K |
|
1952
iShares MSCI Sweden ETF
EWD
$595M
| $1.62M | ﹤0.01% |
49,250
-1,270
| -3% | -$43.3K |
|
|
CLDT
1953
Chatham Lodging
CLDT
$586M
| $1.62M | ﹤0.01% |
169,625
-1,775
| -1% | -$16.9K |
|
1954
Zentalis Pharmaceuticals
ZNTL
$302M
| $1.62M | ﹤0.01% |
80,870
+14,070
| +21% | +$357K |
|
|
ARGO
1955
DELISTED
Argo Group International Holdings, Ltd.
ARGO
| $1.61M | ﹤0.01% |
54,073
+2,735
| +5% | +$81.3K |
|
1956
First Busey Corp
BUSE
$2.56B
| $1.61M | ﹤0.01% |
83,912
-512
| -0.6% | -$10.6K |
|
1957
Alphatec Holdings
ATEC
$1.44B
| $1.61M | ﹤0.01% |
124,179
+6,152
| +5% | +$96.4K |
|
|
MFA
1958
MFA Financial
MFA
$933M
| $1.61M | ﹤0.01% |
167,483
+2,246
| +1% | +$24.3K |
|
1959
Iovance Biotherapeutics
IOVA
$2.87B
| $1.6M | ﹤0.01% |
352,167
-12,476
| -3% | -$81.5K |
|
|
NUVL
1960
DELISTED
Nuvalent
NUVL
| $1.6M | ﹤0.01% |
34,849
+2,078
| +6% | +$92.2K |
|
1961
Claros Mortgage Trust
CMTG
$274M
| $1.6M | ﹤0.01% |
143,955
-250
| -0.2% | -$2.85K |
|
1962
Sumitomo Mitsui Financial
SMFG
$164B
| $1.59M | ﹤0.01% |
161,424
+2,652
| +2% | +$24.5K |
|
1963
iShares Russell Mid-Cap ETF
IWR
$57.5B
| $1.59M | ﹤0.01% |
22,939
+4,866
| +27% | +$355K |
|
1964
TG Therapeutics
TGTX
$7.62B
| $1.58M | ﹤0.01% |
189,206
-254
| -0.1% | -$3.54K |
|
1965
Teekay Tankers
TNK
$2.68B
| $1.58M | ﹤0.01% |
37,950
+684
| +2% | +$27.9K |
|
1966
MannKind Corp
MNKD
$1.32B
| $1.58M | ﹤0.01% |
381,768
+5,636
| +1% | +$25.3K |
|
1967
Columbus McKinnon
CMCO
$584M
| $1.57M | ﹤0.01% |
45,027
-6,513
| -13% | -$248K |
|
|
SI
1968
DELISTED
SIEMENS AKTIENGESELLSCHAFT ADS
SI
| $1.57M | ﹤0.01% |
21,983
+255
| +1% | +$18.2K |
|
|
PGRE
1969
DELISTED
Paramount Group
PGRE
| $1.57M | ﹤0.01% |
339,769
-780
| -0.2% | -$3.85K |
|
|
SAGE
1970
DELISTED
Sage Therapeutics
SAGE
| $1.56M | ﹤0.01% |
76,044
+784
| +1% | +$22.6K |
|
1971
Sweetgreen
SG
$642M
| $1.56M | ﹤0.01% |
133,124
+1,525
| +1% | +$21.2K |
|
1972
KE Holdings
BEKE
$18.8B
| $1.56M | ﹤0.01% |
100,741
+8,070
| +9% | +$128K |
|
|
SOVO
1973
DELISTED
Sovos Brands, Inc. Common Stock
SOVO
| $1.56M | ﹤0.01% |
69,332
+15,666
| +29% | +$329K |
|
1974
Liberty Media Series A
FWONA
$23.6B
| $1.56M | ﹤0.01% |
27,511
+55
| +0.2% | +$3.35K |
|
1975
Pitney Bowes
PBI
$2.39B
| $1.55M | ﹤0.01% |
514,081
-11,232
| -2% | -$38.5K |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2023 Portfolio in Review
As of Q3 2023, RhumbLine Advisers held 4,488 positions worth $86.2B, down 3.5% from $89.3B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Trading was light in Q3 2023: portfolio turnover was 4.6%. RhumbLine Advisers opened 66 new positions and exited 141, leaving the 4,488-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Financials.
- RhumbLine Advisers's largest Q3 2023 buy was Kenvue: 3,131,012 shares worth $62.9M.
- RhumbLine Advisers added most to iShares Russell 1000 ETF in Q3 2023, an estimated $54.4M increase.
- RhumbLine Advisers's biggest Q3 2023 reduction was Johnson & Johnson, cutting an estimated $57.8M.
- RhumbLine Advisers fully exited Life Storage, Inc. in Q3 2023, selling an estimated $39.6M.
- RhumbLine Advisers's ten largest holdings make up 25% of its $86.2B portfolio in Q3 2023.
- RhumbLine Advisers opened 66 new positions and closed 141 in Q3 2023.
- RhumbLine Advisers's portfolio value fell 3.5% quarter-over-quarter to $86.2B.
Based on RhumbLine Advisers's 13F filing for Q3 2023, filed 9 Nov 2023.